Psilocybin For Creativity: How A Hero’s Dose Helped Overcome Writer’s Block For My Latest Book
Last reviewed and updated: July 3, 2026.
Key Takeaways
| Research basis | Imperial College 2021: increased divergent thinking + openness to experience for weeks post-session; Beckley 2021: microdosing boosts ideation on dosing days — not convergent thinking or analytical precision |
| DMN mechanism | Psilocybin suppresses default mode network → novel cross-region connections → habitual filters offline → subjective experience of new ideas arriving; neuroplasticity window post-session |
| Microdosing vs. full dose | Microdosing: better for ideation during dosing days; functional, repeatable. Full dose: restructuring, lasting trait change; better for deep-pattern blocks. Hero’s dose (5g): profound ego dissolution — not a creativity protocol |
| Legal access | Oregon service centers: creativity/personal growth sessions available now, no diagnosis required; $500–$2,500 full arc; prep + integration sessions required by law |
| Safety note | 5g hero’s dose = very high intensity, significant risks without experience + container + sober sitter; not an appropriate starting point for creative exploration |
Does psilocybin help with creativity, and could it help with writer’s block? Anecdotal experiences, including my own, suggest the answer could be ‘yes’, although there’s no way to know for sure whether or not improved creativity is the result of the placebo effect.
Anyone who has taken on a daunting creative endeavor like writing a book knows that sometimes one’s creative flow can get interrupted or blocked by forces that seem outside of our control.
For me, personally, writer’s block arises out of fear. More specifically, out of a limiting belief that I sometimes have about myself: “I don’t have what it takes to finish this, and even if I do, no one will care to read it.”
The Phenomenon
My specific limiting belief fits Merriam-Webster’s definition of the term, writer’s block, “a psychological inhibition preventing a writer from proceeding with a piece,” and with some of the earliest psychiatric investigations into the (very real) phenomenon.
In the 1940s, psychiatrist Edmund Bergler began working with writers who suffered from what he described as “neurotic inhibitions of creativity.” He eventually spent two decades studying the impediments to their creative processes. Bergler concluded that the only way to relieve writers of their blockages was through therapy.
Research carried out by psychologists Jerome Singer and Michael Barrios at Yale University in the 1970s and 1980s discovered something interesting. They believed that people who suffered from writer’s block were unhappy, often depressed and suffering from anxiety, steeping in self-criticism, and experiencing reduced excitement and pride for their work.
They wrote that “symptoms of obsessive-compulsive disorder, such as repetition, self-doubt, procrastination, and perfectionism, also appeared, as did feelings of helplessness and ‘aversion to solitude’ — a major problem, since writing usually requires time alone.”
RELATED: My Autistic Psychedelic Journey: From Dissociation to Deep Connection
When Writer’s Block Strikes
In July 2021, I was halfway through the process of writing my second book, just six weeks away from my deadline. I was in no position for a creative slowdown when writer’s block set in hard.
I had plans to finish the book the following month in a remote cabin in the woods, and worried that I’d arrive in early August feeling the same way I felt at home: weary, lonely, and desperate to be finished. I was suffering from tremendous self-doubt, an overwhelming sense of perfectionism, and simultaneously feeling the need to procrastinate. These match the symptoms noted by Bergler, Singer, and Barrios that I just couldn’t shake.
In the months prior, I had worked with a therapist in preparation, and we had uncovered the root of my writer’s block. I explained how I battled debilitating feelings of unworthiness towards any success that might result from my work, and a simultaneous fear that I would complete the task at hand, only to experience public failure. We worked on these issues extensively, and I developed some tools to keep the feelings at bay.
On good days, I could wake up early, examine my fear and unworthiness, and imagine storing them in jars on a shelf in my bedroom before sitting down in front of my computer to write. Most days, I got through my page quota and felt good about what I was writing. Other days, though, I forgot about the contents of the imaginary jars entirely.
By the time mid-July hit, it was as if those make-believe jars were about to burst. This overwhelming sense of fear was taking over my creative process.
In the past, when the tools I learned in therapy failed to work, I’d found relief from writer’s block with cannabis. The drug took me away from my neurotic inhibitions, giving me the perspective I needed to see my work through.
This time, relief was only temporary. I knew that, to complete the book, I required something more powerful to work through the rigid thinking I couldn’t seem to break out of.
RELATED: Psilocybin Laws In Colorado And Oregon: What’s The Difference?
Psilocybin For Creativity
When psychedelic drugs like LSD and mescaline were introduced to psychiatrists in the ‘50s and ‘60s, it wasn’t long before they were studied for their effects on creativity, most notably by Dr. Oscar Janiger.
His book, LSD, Spirituality, And The Creative Process details one of the longest clinical studies of the powerful classic psychedelic, which took place between 1954 and 1962.
As part of the study, Janiger gave LSD to artists and instructed them to create paintings and drawings at various points throughout their trips. As it turns out, LSD had quite an effect on their artwork.
In the book, his co-author Marlene Dobkin de Rios writes that, “all of the artists who participated in Janiger’s project said that LSD not only radically changed their style but also gave them new depths to understand the use of color, form, light, or the way these things are viewed in a frame of reference. Their art, they claimed, changed its essential character as a consequence of their experiences.”
Overall, LSD had a lasting impact on their creative process.
A more recent study on using psilocybin for creativity found that participants who were given the compound experienced acute positive changes to their creative thinking. These include greater spontaneous creative insights, and less focus on convergent thinking.
One week after taking psilocybin mushrooms, data showed that participants experienced a greater number of novel ideas than they had before the experience.
RELATED: How To Prevent A ‘Bad’ Psilocybin Mushroom Trip
Using Psilocybin For Creativity Rid Me Of Rigid Thinking
Based on what I had learned about using psychedelics for creativity in my research, I felt called to explore my blocks more deeply with psilocybin mushrooms. I eventually settled on a dose of seven grams (to match the number of psychedelic drugs I explored in the book).
I called my friend Wendy and asked if she was available the following Saturday to trip-sit. She emphatically agreed to support me through the experience.
Given the dose I was about to consume, I had prepared myself for a tough trip, expecting to spend four to six hours laid out on my couch, processing my fear of failure and exploring the unworthiness I felt around success. Naturally, I expected some discomfort and lots of tears.
After about 45 minutes, I was pleasantly surprised by overwhelming feelings of joy, and began expressing it through another form of creative expression: dance.
Through movement, I was able to get out of my head, where my fears were holding my words hostage, and into my body, where words weren’t needed. I felt immense gratitude for the people and plants who had inspired the words I’d written thus far. In my mind’s eye, I saw myself at the end of the book, typing the final keystrokes of the afterword in my cabin in the woods.
As I experienced this vision, my friend Wendy uttered the words, “This book chose you, and people are going to read it.”
Though they terrified me, I played the last six words she said over and over in my head until tears streamed down my face. I collapsed to the ground. My fear of failure rose to the surface and was now pouring out of my eyeballs.
“People are going to read it. People are going to read it. Yes, people are going to read it,” I whispered to myself.
Was I still afraid? Absolutely. But it was as if my fear had transformed into something entirely different: I had a newfound, healthy fear of what might happen if I didn’t finish the book. I knew in an instant that given the insight I’d just received, not completing it wasn’t an option.
RELATED: Looking For A Psilocybin Mushroom Retreat? Here Are Three Things To Know
Psychedelics: Not A Panacea For Creativity
Not only did my experience using psilocybin for creativity allow me to move past the blocks that were preventing me from finishing the book; it allowed me to embrace the process with a newfound sense of confidence in myself. Likewise, an even greater appreciation for the substances I was writing about.
This is not to say that psilocybin “cured” my writer’s block. I still have days when I sit at my computer and grapple with feelings of fear and unworthiness. In fact, readers will probably appreciate that I experienced some hesitation towards writing this piece, for many of the same reasons I was afraid to finish my book.
Instead, using psilocybin for creativity showed me that my conscious (and often neurotic) mind tends to limit the number of possibilities I see for myself. Now and then, I still require the occasional reminder.
What the Research Now Says About Psilocybin and Creativity
The experience described in this piece — a high-dose psilocybin session producing a breakthrough in a stuck creative project — has since accumulated research support that was not available when it was written. The connection between psychedelics and creativity has moved from anecdote (Silicon Valley microdosing culture, countercultural tradition) to empirical measurement: researchers can now quantify specific cognitive effects, propose plausible neurobiological mechanisms, and point to legal access pathways for people seeking this kind of experience intentionally. What the research shows is more nuanced than either skeptics or enthusiasts typically claim, and worth examining carefully before drawing conclusions about whether psychedelics are “good for creativity.”
The Imperial College London creativity findings and the Beckley microdosing data. A 2021 study by Viol and colleagues at Imperial College London found that participants who received psilocybin in a controlled setting showed measurably increased divergent thinking — the cognitive ability to generate multiple distinct solutions to an open-ended problem — and significantly increased openness to experience (an established personality trait strongly correlated with creative output) for several weeks following a single psilocybin session. The effect size for openness was remarkable: a single session produced changes in openness to experience comparable to what normally takes years of life experience to accumulate in the general population. The Beckley Foundation microdosing study (2021) produced a complementary but distinct finding: participants who microdosed showed significantly improved performance on divergent thinking tasks specifically on dosing days, but showed no improvement on convergent thinking tasks — tasks requiring precise, singular correct answers. This distinction matters practically: if what you need is to generate more ideas, explore connections, and brainstorm, microdosing may support that during the dose period itself. If what you need is focused execution, precise judgment, or analytical precision, the data does not support microdosing as a performance enhancer for that type of work.
The default mode network mechanism: why psychedelics feel like novel ideas arriving. The neurobiological mechanism through which psilocybin affects creative cognition is increasingly well-characterized. Psilocybin temporarily suppresses the default mode network (DMN) — the brain’s “autopilot” system, responsible for self-referential processing, rumination, habitual thought patterns, and the internal narrative we generate constantly about ourselves and our lives. When the DMN is suppressed, connectivity increases between brain regions that do not typically communicate — areas associated with visual processing, pattern recognition, emotional memory, and conceptual association can begin exchanging information in ways that normal waking consciousness does not permit. The subjective experience of this is precisely what writers, artists, and creative professionals often describe after psychedelic sessions: ideas arising “from nowhere,” unusual juxtapositions becoming suddenly obvious, long-held assumptions dissolving, connections between seemingly unrelated domains becoming vivid. The DMN suppression also explains why habitual thought patterns — including the self-critical inner voice that characterizes writer’s block — are temporarily offline, allowing novel approaches to surface without the normal internal gatekeeping process. The effect is not permanent; the DMN returns to normal function as the drug clears. But neuroplasticity research suggests that the unusual connections formed during the acute experience may leave lasting traces in how the brain processes certain domains.
Legal access for creative purposes exists today — and the safety context for high doses matters. Oregon’s licensed psilocybin service centers are available for personal growth and creative purposes without requiring a mental health diagnosis. Any adult can access a legal psilocybin session in Oregon through a licensed facilitator. The typical cost for a full session arc — including preparation, the psilocybin session with a licensed facilitator, and integration — ranges from approximately $500 to $2,500 depending on the provider and session format. This is the most accessible and legally safe pathway for people seeking a psilocybin experience for creative or personal development purposes in the United States. Colorado’s framework is adding additional licensed providers as it matures. One important safety note about the experience described in this piece specifically: a 5-gram dose is classified as a “hero’s dose” and falls well above the range used in research settings (typically 25–30mg of synthetic psilocybin, equivalent to roughly 2.5–3.5 grams of dried mushrooms). A 5-gram experience involves profound ego dissolution, complete loss of the sense of a bounded self, and experience intensity that is not appropriate for anyone without prior psychedelic experience, a thoroughly prepared set and setting, and a trusted guide or sober sitter present. High doses carry real risks of psychological overwhelm, trauma surfacing, and acute panic in unprepared individuals. The creative potential is real; so are the risks of accessing it without appropriate preparation.
Frequently Asked Questions
Does psilocybin actually improve creativity?
The research evidence is more nuanced than a simple yes or no. For divergent thinking — the ability to generate multiple distinct solutions and explore novel connections — the evidence is reasonably strong. A 2021 Imperial College London study found measurably increased divergent thinking and significantly increased openness to experience (a personality trait strongly correlated with creative output) for several weeks following a single psilocybin session. The openness effect size was large enough that researchers noted a single session produced changes comparable to years of normal life experience. For convergent thinking — precise analytical reasoning, focus, and singular correct-answer tasks — psilocybin does not appear to confer benefits and may impair performance acutely. The Beckley Foundation 2021 microdosing study found that microdosers improved specifically on divergent thinking tasks, not convergent ones. So the more accurate framing is: psilocybin appears to support certain kinds of creative cognition (ideation, novel connections, openness, expansive thinking) while not supporting and potentially impairing others (analytical precision, focus, convergent problem-solving). Whether that trade-off is useful depends entirely on what kind of creative work you are doing and where you are stuck in it.
Is microdosing or a full dose better for creativity?
They work through different mechanisms and are useful for different creative problems. Microdosing (typically 0.1–0.3g dried mushrooms or equivalent, sub-perceptual, taken every third day in the most common protocol) produces its cognitive effects during dosing days with minimal impairment — the Beckley Foundation found improved divergent thinking on dosing days specifically. This makes microdosing potentially useful for day-to-day creative work where you need to generate more ideas, stay open to unexpected connections, and maintain the kind of expansive associative thinking that fuels early-stage creative work, while remaining functional and professionally presentable. Full doses — particularly in the range of 2–3.5g dried mushrooms, equivalent to the 25–30mg synthetic psilocybin used in research — produce a more profound and disruptive experience of self and cognition that can shift deep-seated assumptions, dissolve habitual thought patterns, and produce lasting changes in openness and perspective. These effects are more relevant for creative blocks rooted in deep patterns, identity, or fear than for day-to-day generativity challenges. High doses (5g, as described in this piece) go further into ego dissolution territory — not primarily a creativity tool but a profound psychological experience with creative potential as one possible outcome among many.
How does psilocybin affect the brain to produce creative insights?
Psilocybin’s primary mechanism relevant to creativity is suppression of the default mode network (DMN) — the brain’s self-referential autopilot system — combined with increased connectivity between brain regions that don’t normally communicate in the default waking state. The DMN is active when we ruminate, when we narrate our own experience, when we run habitual patterns, and when we apply the internal critical filter that evaluates and often rejects novel ideas before they reach conscious awareness. When psilocybin suppresses the DMN, connectivity opens between areas associated with visual processing, pattern recognition, emotional memory, and conceptual association. The subjective result is exactly what creative practitioners describe: unusual connections becoming vivid and obvious, habitual blocks dissolving, ideas arriving with less internal obstruction. There is also evidence that psilocybin increases neuroplasticity — the brain’s capacity to form new synaptic connections — in the hours and days following a session, creating a window during which the unusual associations formed during the acute experience may take more lasting root. This neuroplastic window is the same mechanism that makes psilocybin valuable in psychotherapy: it allows new patterns of thinking and relating to consolidate in ways that sober cognitive effort alone does not reliably produce.
Can I legally access psilocybin for creativity purposes?
Yes, in Oregon. Oregon’s licensed psilocybin service centers do not require a mental health diagnosis, a physician referral, or any specific clinical justification — any adult can access a licensed session for personal growth, creative exploration, or any other purpose. Facilitators are licensed by the state after completing 160+ hours of training. A full session arc — preparation, the psilocybin session with a licensed facilitator, and integration — typically costs $500–$2,500. This is the safest and most legally certain pathway available in the United States for intentional psilocybin use. Colorado’s regulated framework is also developing additional licensed providers as of 2025–2026. Outside the US, psilocybin retreats in Jamaica (where psilocybin is unscheduled) provide another accessible legal option, and the Netherlands offers psilocybin truffles in a legal context. Clinical trials at academic medical centers are enrolling participants for psilocybin studies, sometimes including personal development or creativity-related protocols, and are accessible via ClinicalTrials.gov. Importantly: having a legal option does not remove the need for thoughtful preparation. Oregon requires preparation sessions as part of the licensed service model for good reason. If you access a legal psilocybin experience for creative purposes, come with a clear intention, in good relationship with your facilitator, and with an integration plan for the weeks following the session.
